Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Altria

FDA orders Juul e-cigarettes off U.S. market

In 2021, FDA removed thousands of electronic cigarettes off U.S. shelves but delayed its decision on Juul.

The FDA Is Set To Ban Juul Products In U.S.: What Companies Could Benefit?

The FDA Is Set To Ban Juul Products In U.S.: What Companies Could Benefit?

The FDA knows nicotine is addictive. It wants to regulate it for the first time

The FDA knows nicotine is addictive. It wants to regulate it for the first time

The Food and Drug Administration is poised to set a maximum nicotine level in cigarettes and some other tobacco products, looking to make them less addictive and wean smokers off the habit.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

5 Inexpensive Blue-Chip Stocks to Add to Your Portfolio

The increasing concerns over a potential recession has kept equities under pressure lately. Given this backdrop, inexpensive blue-chip stocks of Enterprise Products Partners (EPD), Flowers Foods (FLO), The Kroger (KR), Altria Group (MO), and Comcast Corp. (CMCSA) could be solid additions to your portfolio. Continue reading.

Why Altria Stock Is Down More Than 8% Today

Altria Group Inc (NYSE: MO) shares are trading lower Wednesday following reports the U.S. Food and Drug Administration is preparing to remove Juul e-cigarettes from the U.S. market.

5 Blue Chip Dividend Stocks Yielding More Than 4%

The stock markets pulled back yesterday after the Fed rate hike amid recessionary concerns. Considering the volatile market backdrop, investing in dividend-paying blue-chip stocks AT&T (T), LyondellBasell Industries N.V. (LYB), The Bank of Nova Scotia (BNS), International Business Machines Corp. (IBM), and Altria Group (MO) could be wise.

Why Altria Stock Is Falling Today

Altria Group Inc (NYSE: MO) shares are trading lower Wednesday following bearish analyst coverage from Morgan Stanley.

inkl

Read news from The Economist, FT, and more,
with one subscription

Proposed menthol ban highlights debate over ‘sin tax’ revenue

WASHINGTON — A proposed federal ban on menthol cigarettes has underscored the tension lawmakers face in using so-called “sin tax” revenue to fund critical social programs at the state and federal levels.

Tribune News Service

Proposed menthol ban highlights debate over ‘sin tax’ revenue - Roll Call

Proposed menthol ban highlights debate over ‘sin tax’ revenue - Roll Call

The FDA’s proposed ban on menthol cigarettes means states would see “sin tax” revenues fall, but vaping taxes are already filling the gap.

Marlboro Maker Altria Clocks 2.4% Revenue Decline In Q1; Reaffirms FY22 EPS Outlook

Marlboro Maker Altria Clocks 2.4% Revenue Decline In Q1; Reaffirms FY22 EPS Outlook

Altria Group Inc (NYSE:MO) reported a first-quarter FY22 sales decline of 2.4% year-on-year to $5.89 billion. Revenues net of excise taxes fell 1.3% to $4.82 billion. Net revenues for smokeable products increased 0.3%, and oral tobacco products fell 2.1%. Total cigarette volume declined 12%, with Marlboro shipment volume down 11.1%. Marlboro retail share…

4 Top Stocks to Invest in if We Head into a Recession

4 Top Stocks to Invest in if We Head into a Recession

Lingering supply crunch and soaring inflation have increased the odds of the Fed raising interest rates aggressively later this year, which could dampen corporate earnings. Moreover, as the GDP is estimated to be lower than the prior estimate, many analysts expect the economy to witness recessionary pressure. Therefore, it could…

Altria says judge has dismissed lawsuit over Juul investment

Altria says judge has dismissed lawsuit over Juul investment

Altria says an administrative law judge dismissed a federal lawsuit alleging that its investment into vaping company Juul violates anticompetitive laws

The Independent UK

Altria Stock Gains On Q4 Earnings Beat

Altria Stock Gains On Q4 Earnings Beat

Altria Group Inc (NYSE:MO) reported fourth-quarter FY21 revenues net of excise taxes of $5.09 billion, +0.6% year-on-year, beating the analyst consensus of $5 billion. Net revenues declined 0.8% to $6.26 billion. Revenue for smokeable products increased 2.3%, and oral tobacco products rose 4.8%. Gross profit climbed 5.4% Y/Y to $3.3 billion. The operating…

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Food and Drug Administration

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

355,365 stories

Washington D.C.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play